TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years March 6, 1998
TCL Archive Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members February 3, 1984
TCL Archive High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I April 27, 2001
